Diabetic Testing Supply Access Act of 2013

H.R. 962 / S. 452 - Medicare Diabetes Prevention Act of 2013 H.R. 1074 / S. 539 - National Diabetes Clinical Care Commission Act H.R. 1257 - Preventing Diabetes in Medicare Act H.R. 1274 / S. 945 - Access to Quality Diabetes Education Act of 2013 S. 557 - Medication Therapy Management Empowerment Act H.R. 3322 - Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2013 H.R. 2845 / S. 1935 - Diabetic Testing Supply Access of 2013/14 H.R. 3591 - Minority Diabetes Initiative Act H.R. 2415 / S. 1184 - Treat and Reduce Obesity Act of 2013 S. 596 - Fostering Independence Through Technology Act of 2013 H.R. 2524 / S. 1228 - Medicare Better Health Rewards Program Act of 2013

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Fairness for Small Pharmacies in Part D Preferred Networks; Lifting Prohibition for Home Delivery of Diabetes Testing Supplies Home Delivery (H.R. 2845/S. 1935) ; S.644- The Preventing Abuse of Cough Treatments Act of 2013; H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013;H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; TRICARE Pharmacy Benefit/Provisions; Medicaid Reimbursement Cuts; PBM audit and generic pricing transparency and pricing reform; S. 867 - Medicare Prescription Drug Program Integrity and Transparency Act of 2013; CMS proposed rule on Medicare Part D; H.R. 4069 - Ensuring Patient Access and Effective Drug Enforcement Act of 2013; H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54.

Client expense: $420,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE

S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957- Drug Supply Chain Security Act; H.R. 1919- Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3089- Compounding Clarity Act of 2013; H.R. 3204 - Drug Quality and Security Act; H.R. 2845 - Diabetic Testing Supply Access Act of 2013; S.867- The Medicare Prescription Drug Program Integrity and Transparency Act of 2013

Client expense: $240,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE